StonvexLoading…
StonvexStonvexStonvexCore line items from UTGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $42.35M | $84.91M | $26.31M | $69.71M |
Operating Income | $21.87M | $63.17M | $2.81M | $43.94M |
Net Income | $17.08M | $50.01M | $2.66M | $34.26M |
EPS (Diluted) | $5.42 | $15.80 | $0.84 | $10.81 |
Total Assets | $491.37M | $476.95M | $441.71M | $447.53M |
Total Liabilities | $258.68M | $260.11M | $280.02M | $289.51M |
Cash & Equivalents | $30.54M | $45.26M | $41.19M | $45.29M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 3.14M | 3.16M | 3.17M | 3.16M |